Previous Section
Review Articles
21. Effect of epidermal growth factor receptor tyrosine kinase domain mutations on the outcome of patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.
- Author
- Janne PA; Johnson BE;
- Institution
- Lowe Center for Thoracic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA. pjanne@partners.org
- Journal
- Clin Cancer Res. 2006 Jul 15;12(14 Pt 2):4416s-4420s.
- Abstract URL
- Click here to view abstract
22. The evolving role of cetuximab in non-small cell lung cancer.
- Author
- Lilenbaum RC;
- Institution
- Thoracic Oncology Program, Mount Sinai Cancer Center, Miami Beach, Florida 33140, USA. rlilenba@salick.com
- Journal
- Clin Cancer Res. 2006 Jul 15;12(14 Pt 2):4432s-4435s.
- Abstract URL
- Click here to view abstract
23. Adjuvant therapy in the elderly: making the right decision.
- Author
- Muss HB; Biganzoli L; Sargent DJ; Aapro M;
- Institution
- University of Vermont and Vermont Cancer Center, Burlington, VT 05401, USA. hyman.muss@uvm.edu
- Journal
- J Clin Oncol. 2007 May 10;25(14):1870-5.
- Abstract URL
- Click here to view abstract
24. Where next for gefitinib in patients with lung cancer?
- Author
- Blackhall F; Ranson M; Thatcher N;
- Institution
- Cancer Research UK Department of Medical Oncology, Christie Hospital NHS Trust Manchester, M20 4BX, UK. Fiona.Blackhall@christie-tr.nwest.nhs.uk
- Journal
- Lancet Oncol. 2006 Jun;7(6):499-507.
- Abstract URL
- Click here to view abstract
25. Current approaches to advanced-stage non-small-cell lung cancer: first-line therapy in patients with a good functional status.
- Author
- Stinchcombe TE; Lee CB; Socinski MA;
- Institution
- Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill 27599-7305, USA.
- Journal
- Clin Lung Cancer. 2006 May;7 Suppl 4:S111-7.
- Abstract URL
- Click here to view abstract
26. Pemetrexed in small-cell lung cancer: background and review of the ongoing GALES pivotal trial.
- Author
- Ferraldeschi R; Thatcher N; Lorigan P; Ferraldeschi R; Thatcher N; Lorigan P;
- Institution
- Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK. roberta_ferraldeschi@yahoo.com
- Journal
- Expert Rev Anticancer Ther. 2007 May;7(5):635-40.
- Abstract URL
- Click here to view abstract
27. Angiogenesis inhibitors in lung cancer: a promise fulfilled.
- Author
- Dy GK; Adjei AA;
- Institution
- Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
- Journal
- Clin Lung Cancer. 2006 May;7 Suppl 4:S145-9.
- Abstract URL
- Click here to view abstract
28. Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: a systematic review of randomized controlled trials.
- Author
- Rajeswaran A; Trojan A; Burnand B; Giannelli M;
- Institution
- Faculty of Biology and Medicine, University of Lausanne, Switzerland.
- Journal
- Lung Cancer. 2008 Jan;59(1):1-11. Epub 2007 Aug 27.
- Abstract URL
- Click here to view abstract
29. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer.
- Author
- Lo SS; Fakiris AJ; Papiez L; Abdulrahman R; McGarry RC; Henderson MA; Forquer JA; Hoopes D; Timmerman RD;
- Institution
- Ohio State University Medical Center, Department of Radiation Medicine, Arthur G James Cancer Hospital, 300 West 10th Avenue, Suite 088A, Columbus, OH 43210, USA. simon.lo@osumc.edu
- Journal
- Expert Rev Anticancer Ther. 2008 Jan;8(1):87-98.
- Abstract URL
- Click here to view abstract
30. Molecular biologic staging of lung cancer.
- Author
- D'Amico TA;
- Institution
- Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA. damic001@mc.duke.edu
- Journal
- Ann Thorac Surg. 2008 Feb;85(2):S737-42.
- Abstract URL
- Click here to view abstract
